Ionis Pharmaceuticals, Inc. (IONS)
42.93
-0.98
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
42.91
-0.02
(-0.05%)
After-Hours: 20:00
Ionis Pharmaceuticals Price to Book Value : 16.17 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 16.17 |
| October 22, 2026 | 16.54 |
| October 21, 2026 | 16.68 |
| October 20, 2026 | 17.10 |
| October 19, 2026 | 16.72 |
| October 16, 2026 | 16.17 |
| October 15, 2026 | 16.62 |
| October 14, 2026 | 16.08 |
| October 13, 2026 | 15.96 |
| October 12, 2026 | 16.45 |
| October 09, 2026 | 17.06 |
| October 08, 2026 | 16.31 |
| October 07, 2026 | 16.63 |
| October 06, 2026 | 16.57 |
| October 05, 2026 | 16.39 |
| October 02, 2026 | 16.40 |
| October 01, 2026 | 16.57 |
| September 30, 2026 | 16.82 |
| September 29, 2026 | 17.29 |
| September 28, 2026 | 17.16 |
| September 25, 2026 | 16.76 |
| September 24, 2026 | 16.50 |
| September 23, 2026 | 16.55 |
| September 22, 2026 | 17.23 |
| September 21, 2026 | 16.91 |
| Date | Value |
|---|---|
| September 18, 2026 | 16.74 |
| September 17, 2026 | 17.61 |
| September 16, 2026 | 16.89 |
| September 15, 2026 | 17.80 |
| September 14, 2026 | 19.38 |
| September 11, 2026 | 20.42 |
| September 10, 2026 | 20.96 |
| September 09, 2026 | 21.10 |
| September 08, 2026 | 21.36 |
| September 04, 2026 | 21.88 |
| September 03, 2026 | 21.90 |
| September 02, 2026 | 23.10 |
| September 01, 2026 | 22.56 |
| August 31, 2026 | 22.74 |
| August 28, 2026 | 23.00 |
| August 27, 2026 | 23.52 |
| August 26, 2026 | 23.87 |
| August 25, 2026 | 23.94 |
| August 24, 2026 | 23.37 |
| August 21, 2026 | 22.50 |
| August 20, 2026 | 22.13 |
| August 19, 2026 | 22.90 |
| August 18, 2026 | 22.46 |
| August 17, 2026 | 22.08 |
| August 14, 2026 | 21.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Biogen, Inc. | 1.964 |
| BridgeBio Pharma, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 6.556 |
| Amgen, Inc. | 20.32 |
Price to Book Value Related Metrics
| PS Ratio | 8.009 |
| PEG Ratio | -0.1412 |
| Price | 42.93 |
| Earnings Yield | -8.09% |
| Market Cap | 7.111B |
| PEGY Ratio | -0.1412 |